Caeregen Therapeutics
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
510 Meadowmont Village Cir Pmb 301, Chap...Phone Number
(984) 309-8915Website
www.caeregen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Caeregen Therapeutics
Caeregen Therapeutics, LLC, based in Rochester, MI with offices in Chapel Hill, N.C., is a regenerative medicines company developing therapeutics for neurosensory diseases. By exploiting biological pathways and signaling related to cellular and organ development, Caeregen is focused on advancing targeted therapies with the ability to repair, restore and protect neurosensory tissues affected by inherited or acquired diseases. Caeregen is currently developing Noregen, a unique, novel, recombinant protein mimetic of human norrin-derived growth factor for the potential treatment of retinal-related vision loss.Explore more
Caeregen Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Caeregen Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Caeregen Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Caeregen Therapeutics
Check if Caeregen Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Caeregen Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Caeregen Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Caeregen Therapeutics launches new products
Check out if Caeregen Therapeutics is spiking on competitors!
Earning: See what the market has to say on Caeregen Therapeutics recently announced quarterly report
Recommended Actions
Find VP level buyers at Caeregen Therapeutics
Find 3 more new buyers
Compare Similar Companies to Caeregen Therapeutics
Compare insights from companies similar to Caeregen Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Caeregen Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Caeregen Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Caeregen Therapeutics.
Caeregen Therapeutics Tech Stack
A closer look at the technologies used by Caeregen Therapeutics
See more technologies
Caeregen Therapeutics News & Media
Caeregen Therapeutics Receives $1.4 Million Phase 2 SBIR Grant from NIH/NEI to Advance Development of Regenerative Medicine Clinical Candidate CTR-107 (Noregen™) for Retinal Diseases
ROCHESTER, Mich.--(BUSINESS WIRE)--Caeregen Therapeutics Receives $1.4 M Phase 2 SBIR Grant to Advance Development of Regenerative Medicine Clinical Candidate for Retinal DiseasesCaeregen Therapeutics and Wacker Biotech Announce Collaboration Agreement to Produce the Regenerative Medicine Clinical Candidate CTR-107 (Noregen™) for Retinal Diseases
ROCHESTER, Mich. & HALLE, Germany--(BUSINESS WIRE)--Caeregen Therapeutics and Wacker Biotech announce collaboration agreement to produce regenerative medicine clinical candidate for retinal diseases
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Caeregen Therapeutics
Sign Up For FreeTo access detailed company insights
Caeregen Therapeutics, LLC, based in Rochester, MI with offices in Chapel Hill, N.C., is a regenerative medicines company developing therapeutics for neurosensory diseases. By exploiting biological pathways and signaling related to cellular and organ development, Caeregen is focused on advancing targeted therapies with the ability to repair, restor... Read More
